Covalon Technologies (OTCMKTS:CVALF - Get Free Report) released its earnings results on Tuesday. The company reported $0.01 earnings per share (EPS) for the quarter, Zacks reports. Covalon Technologies had a negative return on equity of 4.40% and a negative net margin of 2.94%.
Covalon Technologies Stock Performance
Shares of OTCMKTS CVALF traded down $0.20 during mid-day trading on Tuesday, reaching $2.30. The company had a trading volume of 133,145 shares, compared to its average volume of 44,211. Covalon Technologies has a one year low of $0.74 and a one year high of $3.08. The firm has a market cap of $63.02 million, a price-to-earnings ratio of -76.64 and a beta of -0.27. The business's 50-day simple moving average is $2.51 and its 200 day simple moving average is $2.18.
About Covalon Technologies
(
Get Free Report)
Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company's platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.
Read More
Before you consider Covalon Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Covalon Technologies wasn't on the list.
While Covalon Technologies currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
